Cytotoxic T Lymphocyte Responses Against Melanocytes and Melanoma
Author Information
Author(s): Chang Gwendolen Y, Kohrt Holbrook E, Stuge Tor B, Schwartz Erich J, Weber Jeffrey S, Lee Peter P
Primary Institution: Stanford University School of Medicine
Hypothesis
Do cytotoxic T lymphocytes respond differently to melanoma cells and normal melanocytes?
Conclusion
Cytotoxic T lymphocytes respond to melanoma and melanocytes equally in vitro and directly ex vivo.
Supporting Evidence
- Cytotoxic T lymphocytes from melanoma patients can kill both melanoma and melanocyte cells.
- Melanocytes showed equal to slightly higher responses from T lymphocytes compared to melanoma cells.
- MAA-specific T cells from vaccinated patients responded to both melanoma and melanocytes.
Takeaway
The study found that immune cells that attack melanoma also target normal skin cells, which could explain some side effects of treatment.
Methodology
The study characterized the functional reactivities of cytotoxic T lymphocyte clones against melanoma and melanocyte cell lines.
Potential Biases
Potential bias due to the small number of patients and the specific patient population studied.
Limitations
The study had a small sample size and limited patient samples.
Participant Demographics
Patients with resected stage III or IV melanoma.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website